Search Ontology:
ChEBI
Lactosylceramide (d18:1/12:0)
- Term ID
- CHEBI:89446
- Synonyms
-
- 1-O-(4-O-b-D-Galactopyranosyl-b-D-glucopyranosyl)-Ceramide
- 1-O-(4-O-beta-D-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1-O-(4-O-beta-delta-Galactopyranosyl-beta-delta-glucopyranosyl)-Ceramide
- 1-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1ylce-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- beta-D-Galactosyl-1,4-beta-D-Glucosylceramide
- beta-delta-Galactosyl-1,4-beta-delta-glucosramide
- beta-delta-Galactosyl-1,4-beta-delta-Glucosylceramide
- CDH
- CDw17 antigen
- Cytolipin H
- D-Galactosyl-1,4-beta-D-glucosylceramide
- delta-Galactosyl-1,4-beta-delta-glucosylceramide
- Gal-beta1->4Glc-beta1->1'Cer
- LacCer
- LacCer(d18:1/12:0)
- Lactosyl ceramide (d18:1/12:0)
- Lactosyl-N-acylsphingosine
- Lactosylceramide
- N-(Dodecanoyl)-1-b-lactosyl-sphing-4-enine
- N-(Dodecanoyl)-1-beta-lactosyl-sphing-4-enine
- N-[(2S,3R,4E)-1-{[(2R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]dodecanamide
- N-Lignoceryl sphingosyl lactoside
- Definition
- References
-
- CAS:4682-48-8
- HMDB:HMDB0004866
- LIPID_MAPS_instance:LMSP0501AB02
- MetaCyc:CYTOLIPIN_H
- PMID:10320813
- PMID:12070301
- PMID:12409508
- PMID:12417418
- PMID:12438625
- PMID:12486134
- PMID:12566244
- PMID:12829005
- PMID:15918012
- PMID:16166299
- PMID:178813
- PMID:3396945
- PMID:403037
- PMID:9106497
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
Phenotype
Phenotype resulting from Lactosylceramide (d18:1/12:0)
Phenotype where environments contain Lactosylceramide (d18:1/12:0)
Phenotype modified by environments containing Lactosylceramide (d18:1/12:0)
Human Disease / Model Data